Stabilizing drug molecules in biological samples

Therapeutic Drug Monitoring

Volumn 27, Issue 5, 2005, Pages 617-624

  Chen, Jiwen ^a   Hsieh, Yunsheng ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Drug testing; Stability

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACYLGLUCURONIDE; AMFEBUTAMONE; ANTHRAQUINONE; APOMORPHINE; BENZODIAZEPINE DERIVATIVE; BENZOYLECGONINE; BETAMETHASONE; CARBOXYLESTERASE; CEFETAMET PIVOXIL; CHOLINESTERASE; CISATRACURIUM; CISPLATIN; CLENBUTEROL; COCAINE; DESIGNER DRUG; DILTIAZEM; DRONABINOL; DRUG; ECGONINE; ECGONINE METHYL ESTER; FLUOROURACIL; GEMOPATRILAT; LEVODOPA; METHOTREXATE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; NORCOCAINE; OMAPATRILAT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACCURACY; ANALYTIC METHOD; BIOAVAILABILITY; BIOEQUIVALENCE; BLOOD SAMPLING; DRUG SCREENING; DRUG SELECTIVITY; DRUG STABILITY; HUMAN; INHIBITION KINETICS; METHODOLOGY; MOLECULAR STABILITY; MONKEY; NONHUMAN; PH MEASUREMENT; PLASMA; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; TEMPERATURE SENSITIVITY; VALIDATION PROCESS;

ANIMALS; ANTIOXIDANTS; DRUG STABILITY; ENZYME INHIBITORS; HAPLORHINI; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; PHARMACEUTICAL PREPARATIONS; RATS; TEMPERATURE;

EID: 26444483440     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000170879.18139.40     Document Type: Review

References (75)

1. Korfmacher WA, Cox KA, Ng KJ, et al. Cassette-accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/ atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery. Rapid Commun Mass Spectrom. 2001;15:335-340.
2. Hsieh Y, Chintala M, Mei H, et al. Quantitative screening and matrix effect studies of drug discovery compounds in monkey plasma using fast-gradient liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2001;15:2481-2487.
3. Mei H, Hsieh Y, Nardo C, et al. Investigation of matrix effects in bio-analytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery. Rapid Commun Mass Spectrom. 2003;17:97-103.
4. Hasler F, Bourquin D, Brenneisen R, et al. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharm Acta Helv. 1997;72:175-184.
5. Dufresne C, Favetta P, Paradis C, et al. Stability of sufentanil in human plasma samples. Ther Drug Monit. 2001;23:550-552.
6. Klette KL, Poch GK, Czarny R, et al. Simultaneous GC-MS analysis of meta- and para-hydroxybenzoylecgonine and norbenzoylecgonine: a secondary method to corroborate cocaine ingestion using nonhydrolytic metabolites. J Anal Toxicol. 2002;26:193-200.
7. Ventura R, Jimenez C, Closas N, et al. Stability studies of selected doping agents in urine: caffeine. J Chromatogr B. 2003;795:167-177.
8. Chan BY, Buckley KA, Durham BH, et al. Effect of anticoagulants and storage temperature on the stability of receptor activator for nuclear factor-kappa B ligand and osteoprotegerin in plasma and serum. Clin Chem. 2003;49:2083-2085.
9. Soderberg BL, Sicinska ET, Blodget E, et al. Preanalytical variables affecting the quantification of fatty acid ethyl esters in plasma and serum samples. Clin Chem. 1999;45:2183-2190.
10. Comstock GW, Alberg AJ, Helzisouer KJ. Reported effects of long-term freezer storage on concentrations of retinol, beta-carotene, and alpha-tocopherol in serum or plasma summarized. Clin Chem. 1993;39:1075-1078.
11. Kjeld JM, Puah CM, Joplin GF. Rise of unconjugated sex hormones in human urine on storage. Clin Chim Acta. 1977;80:285-291.
12. Dugan S, Bogema S, Schwartz RW, et al. Stability of drugs of abuse in urine samples stored at -20 degrees C. J Anal Toxicol. 1994;18:391-396.
13. al-Hadidi KA, Oliver JS. Stability of temazepam in blood. Sci Justice. 1995;35:105-108.
14. Romberg RW, Past MR. Reanalysis of forensic urine specimens containing benzoylecgonine and THC-COOH. J Forensic Sci. 1994;39:479-485.
15. Moeller MR, Kraemer T. Drugs of abuse monitoring in blood for control of driving under the influence of drugs. Ther Drug Monit. 2002;24:210-221.
16. http://www.fda.gov/cder/guidance/4252M.pdf
17. Clauwaert KM, Van Bocxlaer JF, De Leenheer AP. Stability study of the designer drugs "MDA, MDMA, and MDEA" in water, serum, whole blood, and urine under various storage temperatures. Forensic Sci Int. 2001;124:36-42.
18. Drummer OH, Gerostamoulos J. Postmortem drug analysis: analytical and lexicological aspects. Ther Drug Monit. 2002;24:199-209.
19. Robertson MD, Drummer OH. Stability of nitrobenzodiazepines in postmortem blood. J Forensic Sci. 1998;43:5-8.
20. Satoh T, Taylor P, Bosron WF, et al. Current progress on esterases: from molecular structure to function. Drug Metab Dispos. 2002;30:488-493.
21. Bouis P, Taccard G, Boelsterli UA. Determination of cocaine and norcocaine in plasma and cell cultures using high-performance liquid chromatography. J Chromatogr. 1990;526:447-459.
22. Boyanton BL, Blick KE. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem. 2002;48:2242-2247.
23. Murphy RF, Balis FM, Poplack DG. Stability of 5-fluorouracil in whole blood and plasma. Clin Chem. 1987;33:2299-2300.
24. Limelette N, Ferry M, Branger S, et, al. In vitro stability study of methotrexate in blood and plasma samples for routine monitoring. Ther Drug Monit. 2003;25:81-87.
25. Guellec CL, Gaudet ML, Lamanetre S, et al. Stability of rifampin in plasma: consequences for therapeutic monitoring and pharmacokinetic studies. Ther Drug Monit. 1997;19:669-674.
26. Dufresne C, Favetta P, Paradis C, et al. Stability of sufentanil in human plasma samples. Ther Drug Monit. 2001;23:550-552.
27. Christophersen AS. Tetrahydrocannabinol stability in whole blood: plastic versus glass containers. J Anal Toxicol. 1986;10:129-131.
28. Gill R, Hatchett SE, Osselton MD, et al. Sample handling and storage for the quantitative analysis of volatile compounds in blood: the determination of toluene by headspace gas chromatography. J Anal Toxicol. 1988;12:141-146.
29. Skopp G, Klingmann A, Potsch L, et al. In vitro stability of cocaine in whole blood and plasma including ecgonine as a target analyte. Ther Drug Monit. 2001;23:174-181.
30. Saxer C, Niina M, Nakashima A, et al. Simultaneous determination of levodopa and 3-O-methyldopa in human plasma by liquid chromatography with electrochemical detection. J Chromatogr B. 2004;802:299-305.
31. Wyss R, Bucheli F. Determination of cefetamet and its orally active ester, cefetamet pivoxyl, in biological fluids by high-performance liquid chromatography. J Chromatogr. 1988;430:81-92.
32. Sam E, Augustijns P, Verbeke N. Stability of apomorphine in plasma and its determination by high-performance liquid chromatography with electrochemical detection. J Chromatogr B. 1994;658:311-317.
33. Clardy DO, Ragle JL. Stability of phencyclidine in stored blood. Clin Toxicol. 1981;18:929-934.
34. Battah AH, Hadidi KA. Stability of trihexyphenidyl in stored blood and urine specimens. Int J Legal Med. 1998;111:111-114.
35. Bonnefous J, Boulieu R, Lahet C. Stability of diltiazem and its metabolites in human blood samples. J Pharm Sci. 1992;81:341-344.
36. Wang G, Hsieh Y. Ultilization of direct HPLC-MS-MS for drug stability measurement. Am Lab. 2002;5:24-27.
37. Wang G, Hsieh Y, Cheng KC, et al. High-throughput cassette assay for drug stability measurement in plasma using direct HPLC-MS/MS. Spectrosc Int J. 2003;17:511-519.
38. Wang G, Hsieh Y, Lau Y, et al. Semi-automated determination of plasma stability of drug discovery compounds using liquid chromatography-tandem mass spectrometry. J Chromatogr B. 2002;780:451-457.
39. Hsieh Y, Bryant MS, Gruela G, et al. Direct analysis of plasma samples for drug discovery compounds using mixed-function column liquid chromatography tandem mass spectrometry. Rapid Commun Mass Spectrom. 2000;14:1384-1390.
40. Hsieh Y, Brisson JM, Ng K, et al. Direct simultaneous analysis of plasma samples for a drug discovery compound and its hydroxyl metabolite using mixed-function column liquid chromatography-tandem mass spectrometry. Analyst. 2001;126:2139-2143.
41. Hsieh Y, Brisson JM, Ng K, et al. Direct simultaneous determination of drug discovery compounds in monkey plasma using mixed-function column liquid chromatography/tandem mass spectrometry. J Pharm Biomed Anal. 2002;27:285-293.
42. Hsieh Y, Bryant MS, Brisson JM, et al. Direct cocktail analysis of drug discovery compounds in pooled plasma samples using liquid chromatography-tandem mass spectrometry. J Chromatogr B. 2002;767:353-362.
43. Hsieh Y, Ng K, Korfmacher WA. Development and application of single-column direct plasma injection procedures for drug candidate assays using HPLC-MS/MS. Am Pharm Rev. 2002;4:88-93.
44. Reynolds DL, Sternson LA, Repta AJ. Clinical analysis for the antineoplastic agent 1,4-dihydroxy-5,8-bis((2-[(2-hydroxyethyl)amino]ethyl)- amino)9,10-anthracenedio ne dihydrochloride (NSC 301739) in plasma. Application of temperature control to provide selectivity in paired-ion high-performance liquid chromatography. J Chromatogr. 1981;222:225-240.
45. Anderson A, Ehrsson H. Stability of cisplatin and its monohydrated complex in blood, plasma and ultrafiltrate-implications for quantitative analysis. J Pharm Biomed Anal. 1995;13:639-644.
46. El Mahjoub A, Staub C. Stability of benzodiazepines in whole blood samples stored at varying temperatures. J Pharm Biomed Anal. 2000;23:1057-1063.
47. Johnson JR, Jennison TA, Peat MA, et al. Stability of delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in blood and plasma. J Anal Toxicol. 1984;8:202-204.
48. Venneri MG, Del Rio G. Systematic study of long-term stability of 3,4-dihydroxyphenylglycol in plasma for subsequent determination with liquid chromatography. J Chromatogr B. 2004;802:247-255.
49. Hashimoto N, Ichihashi T, Hirano K, et al. Epimerization kinetics of moxalactam in frozen urine and plasma samples. Pharm Res. 1990;4:364-369.
50. Fura A, Harper TW, Zhang H, et al. Shift in pH of biological fluids during storage and processing: effect on bioanalysis. J Pharm Biomed Anal. 2003;32:513-522.
51. Welch RM, Brown A, Ravitch J, et al. The in vitro degradation of cisatracurium, the R, cis-R′-isomer of atracurium, in human and rat plasma. Clin Pharmacol Ther. 1995;58:132-142.
52. Vermeire A, Remon JP. Stability and compatibility of morphine. Int J Pharm. 1999;187:17-51.
53. Rindgen D, Grotz D, Clarke NJ, et al. The application of HPLC/tandem mass spectrometry for the assessment of acyl glucuronide metabolite formation in in vitro and in vivo systems in a drug discovery environment. Am Pharm Rev. 2001;4:52.
54. Wainhaus S, White R, Dunn-Meynell K, et al. Semi-quantitation of acyl glucuronides in early drug discovery by LC-MS/MS. Am Pharm Rev. 2002;5:86-92.
55. Ebner T, Heinzel G, Prox A, et al. Disposition and chemical stability of telmisartan I-O-acylglucuronide. Drug Metab Dispos. 1999;27:1143-1149.
56. Skopp GL, Potsch L. Stability of 11-nor-delta(9)- carboxytetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatographytandem mass spectrometry. Clin Chem. 2002;48:301-306.
57. Laizure SC, DeVane CL. Stability of bupropion and its major metabolites in human plasma. Ther Drug Monit. 1985;7:447-450.
58. Jemal M, Hawthorne DJ. Quantitative determination of BMS186716, a thiol compound, in dog plasma by high-performance liquid chromatography-positive ion electrospray mass spectrometry after formation of the methyl acrylate adduct. J Chromatogr B. 1997;693:109-116.
59. Jemal M, Khan S, Teitz DS, et al. LC/MS/MS determination of omapatrilat, a sulfhydryl-containing vasopeptidase inhibitor, and its sulfhydryl-and thioether-containing metabolites in human plasma. Anal Chem. 2001;73:5450-5456.
60. Wang G, Hsieh Y, Wang L, et al. High performance liquid chromatography-atmospheric pressure chemical ionization/tandem mass spectrometry for the determination of a thiol compound in plasma. Anal Chim Acta. 2003;492:215-221.
61. Chen J, Brisson J, Wang G, et al. Methodologies for stabilization of pharmaceuticals in biological samples. Am Lab. (in press).
62. Zhang JY, Fast DM, Schoenhard GL, et al. Quantitative determination of SC-68328 in dog plasma using flow injection and tandem mass spectrometry. J Mass Spectrom. 2000;35:354-360.
63. Paul BD, McWhorter LK, Smith ML. Electron ionization mass fragmentometric detection of urinary ecgonidine, a hydrolytic product of methylecgonidine, as an indicator of smoking cocaine. JMass Spectrom. 1999;34:651-660.
64. Scheidweiler KB, Shojaie J, Plessinger MA, et al. Stability of methylecgonidine and ecgonidine in sheep plasma in vitro. Clin Chem. 2000;46:1787-1795.
65. Scheidweiler KB, Plessinger MA, Shojaie J, et al. Pharmacokinetics and pharmacodynamics of methylecgonidine, a crack cocaine, pyrolyzate. J Pharmacol Exp Ther. 2003;307:1179-1187.
66. Priston MJ, Sewell GJ. Improved LC assay for the determination of mitozantrone in plasma: analytical considerations. J Pharm Biomed Anal. 1994;12:1153-1162.
67. Hu OY, Chang SP, Song YB, et al. Novel assay method for mitoxantrone in plasma, and its application in cancer patients. J Chromatogr. 1990;532:337-350.
68. Slordal L, Andersen A, Warren DJ. A sensitive and simple high-performance liquid chromatographic method for the determination of mitoxantrone in plasma. Ther Drug Monit. 1993;15:328-333.
69. Chung WY, Chung JK, Szeto YT, et al. Plasma ascorbic acid: measurement, stability and clinical utility revisited. Clin Biochem. 2001;34:623-627.
70. Skopp G, Potsch L, Konig I, et al. A preliminary study on the stability of benzodiazepines in blood and plasma stored at 4 degrees C. Int J Legal Med. 1998;11:1-5.
71. Effects of frozen storage on the recovery of clenbuterol from urine samples for official control. Effects of frozen storage on the recovery of clenbuterol from urine samples for official control. Food Addit Contam. 2002;19:1010-1014.
72. Koves EM, Lawrence K, Mayer JM. Stability of diltiazem in whole blood: forensic implications. J Forensic Sci. 1998;43:587-597.
73. Skopp G, Potsch L, Mattern R, et al. Short-term stability of lysergic acid diethylamide (LSD), N-desmethyl-LSD, and 2-oxo-3-hydroxy-LSD in urine, assessed by liquid chromatography-tandem mass spectrometry. Clin Chem. 2002;48:1615-1618.
74. Matsuura K, Murai K, Fukano Y, et al. Simultaneous determination of tiopronin and its metabolites in rat blood by LC-ESI-MS-MS using methyl acrylate for stabilization of thiol group. J Pharm Biomed Anal. 2000;22:101-109.
75. Samtani MN, Schwab M, Nathanielsz PW, et al. Stabilization and HPLC analysis of betamethasone sodium phosphate in plasma. J Pharm Sci. 2004;93:726-732.